Article type
Abstract
Background
The use of evidence and data holds immense promise in reshaping the socioeconomic landscape. Evidence-informed policy-making can support the identification of the most effective policies and programs, ensure the policy decision-making process is more transparent, and allow different stakeholders an option to contribute to policy decision-making. Evidence advocates have long designed interventions to support policy-makers’ use of evidence such as capacity-building and improving access to evidence. However, it is unclear which of these interventions to support the use of evidence work best, why, how, and for whom.
Objectives
This panel will provide insights on what works to increase the use of evidence for policy decision-making based on an evidence map and systematic review of the available evidence base.
Methods
We conducted an evidence map and systematic review of the available evidence base following Campbell Collaboration and 3ie guidelines.
Results
Our evidence map identified 617 studies assessing the effects of interventions supporting the use of evidence for policy decision-making. These studies were then synthesized according to 6 mechanisms of change using meta-analysis and qualitative evidence synthesis. The panel will present the results of both syntheses and discuss the implications thereof for 4 leading evidence organizations: WHO, 3ie, FCDO, and PACE.
Relevance to policymakers
This panel will support policymakers wanting to enhance the use of evidence in their organizations by sharing insights on which interventions to focus on when designing systems and processes to support the use of evidence. The evidence map is already being used by all organizations, and the systematic review will inform a program commissioning new research.
Format
Our panel will be organized as follows:
1.Welcome by chair: 5 mins
2.Presentation of main results from the evidence map and systematic review: 15 mins
3.Implications and use of the results—a WHO perspective: 10 mins
4.Implications and use of the results—a 3ie perspective: 10 mins
5.Implications and use of the results—an FCDO perspective: 10 mins
6.Q&A with audience: 30 mins
7.Closing remarks from panelists and chair: 10 mins
The use of evidence and data holds immense promise in reshaping the socioeconomic landscape. Evidence-informed policy-making can support the identification of the most effective policies and programs, ensure the policy decision-making process is more transparent, and allow different stakeholders an option to contribute to policy decision-making. Evidence advocates have long designed interventions to support policy-makers’ use of evidence such as capacity-building and improving access to evidence. However, it is unclear which of these interventions to support the use of evidence work best, why, how, and for whom.
Objectives
This panel will provide insights on what works to increase the use of evidence for policy decision-making based on an evidence map and systematic review of the available evidence base.
Methods
We conducted an evidence map and systematic review of the available evidence base following Campbell Collaboration and 3ie guidelines.
Results
Our evidence map identified 617 studies assessing the effects of interventions supporting the use of evidence for policy decision-making. These studies were then synthesized according to 6 mechanisms of change using meta-analysis and qualitative evidence synthesis. The panel will present the results of both syntheses and discuss the implications thereof for 4 leading evidence organizations: WHO, 3ie, FCDO, and PACE.
Relevance to policymakers
This panel will support policymakers wanting to enhance the use of evidence in their organizations by sharing insights on which interventions to focus on when designing systems and processes to support the use of evidence. The evidence map is already being used by all organizations, and the systematic review will inform a program commissioning new research.
Format
Our panel will be organized as follows:
1.Welcome by chair: 5 mins
2.Presentation of main results from the evidence map and systematic review: 15 mins
3.Implications and use of the results—a WHO perspective: 10 mins
4.Implications and use of the results—a 3ie perspective: 10 mins
5.Implications and use of the results—an FCDO perspective: 10 mins
6.Q&A with audience: 30 mins
7.Closing remarks from panelists and chair: 10 mins